NFE2L2 and Disorder of lipid metabolism: To summarize, this study revealed the molecular mechanism of Germacrone in improving oxidative stress and lipid metabolism disorder in ALD through inhibition of the Nrf2/Rbp4 pathway, using integrated in vivo and in vitro experimental systems.